Real-World Safety and Effectiveness of Omalizumab in Moderate to Severe Allergic Asthma Patients in China: A Post-Authorization Study.
Su N, Zhi L, Liu F, Wang Y, Zhang Q, Liu X, Wang X, Hao G, Zhang X, Hu Q, Ligueros-Saylan M, Uddin A, Yang J, Liang T, Ding L, Li R, Wang C.
Su N, et al. Among authors: zhang q, zhang x.
J Asthma Allergy. 2023 Jun 19;16:625-636. doi: 10.2147/JAA.S406628. eCollection 2023.
J Asthma Allergy. 2023.
PMID: 37360967
Free PMC article.